Literature DB >> 27364481

The role of enhancers in cancer.

Inderpreet Sur1, Jussi Taipale1,2.   

Abstract

Enhancer elements function as the logic gates of the genetic regulatory circuitry. One of their most important functions is the integration of extracellular signals with intracellular cell fate information to generate cell type-specific transcriptional responses. Mutations occurring in cancer often misregulate enhancers that normally control the signal-dependent expression of growth-related genes. This misregulation can result from trans-acting mechanisms, such as activation of the transcription factors or epigenetic regulators that control enhancer activity, or can be caused in cis by direct mutations that alter the activity of the enhancer or its target gene specificity. These processes can generate tumour type-specific super-enhancers and establish a 'locked' gene regulatory state that drives the uncontrolled proliferation of cancer cells. Here, we review the role of enhancers in cancer, and their potential as therapeutic targets.

Entities:  

Mesh:

Year:  2016        PMID: 27364481     DOI: 10.1038/nrc.2016.62

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  160 in total

1.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

2.  The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling.

Authors:  Sari Tuupanen; Mikko Turunen; Rainer Lehtonen; Outi Hallikas; Sakari Vanharanta; Teemu Kivioja; Mikael Björklund; Gonghong Wei; Jian Yan; Iina Niittymäki; Jukka-Pekka Mecklin; Heikki Järvinen; Ari Ristimäki; Mariachiara Di-Bernardo; Phil East; Luis Carvajal-Carmona; Richard S Houlston; Ian Tomlinson; Kimmo Palin; Esko Ukkonen; Auli Karhu; Jussi Taipale; Lauri A Aaltonen
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

Review 3.  Determinants and dynamics of genome accessibility.

Authors:  Oliver Bell; Vijay K Tiwari; Nicolas H Thomä; Dirk Schübeler
Journal:  Nat Rev Genet       Date:  2011-07-12       Impact factor: 53.242

Review 4.  The role of regulatory variation in complex traits and disease.

Authors:  Frank W Albert; Leonid Kruglyak
Journal:  Nat Rev Genet       Date:  2015-02-24       Impact factor: 53.242

5.  Super-enhancers in the control of cell identity and disease.

Authors:  Denes Hnisz; Brian J Abraham; Tong Ihn Lee; Ashley Lau; Violaine Saint-André; Alla A Sigova; Heather A Hoke; Richard A Young
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

6.  Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.

Authors:  Julius Gudmundsson; Patrick Sulem; Andrei Manolescu; Laufey T Amundadottir; Daniel Gudbjartsson; Agnar Helgason; Thorunn Rafnar; Jon T Bergthorsson; Bjarni A Agnarsson; Adam Baker; Asgeir Sigurdsson; Kristrun R Benediktsdottir; Margret Jakobsdottir; Jianfeng Xu; Thorarinn Blondal; Jelena Kostic; Jielin Sun; Shyamali Ghosh; Simon N Stacey; Magali Mouy; Jona Saemundsdottir; Valgerdur M Backman; Kristleifur Kristjansson; Alejandro Tres; Alan W Partin; Marjo T Albers-Akkers; Javier Godino-Ivan Marcos; Patrick C Walsh; Dorine W Swinkels; Sebastian Navarrete; Sarah D Isaacs; Katja K Aben; Theresa Graif; John Cashy; Manuel Ruiz-Echarri; Kathleen E Wiley; Brian K Suarez; J Alfred Witjes; Mike Frigge; Carole Ober; Eirikur Jonsson; Gudmundur V Einarsson; Jose I Mayordomo; Lambertus A Kiemeney; William B Isaacs; William J Catalona; Rosa B Barkardottir; Jeffrey R Gulcher; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  Nat Genet       Date:  2007-04-01       Impact factor: 38.330

7.  Selectivity, sharing and competitive interactions in the regulation of Hoxb genes.

Authors:  J Sharpe; S Nonchev; A Gould; J Whiting; R Krumlauf
Journal:  EMBO J       Date:  1998-03-16       Impact factor: 11.598

8.  Identification of tissue-specific cell death using methylation patterns of circulating DNA.

Authors:  Roni Lehmann-Werman; Daniel Neiman; Hai Zemmour; Joshua Moss; Judith Magenheim; Adi Vaknin-Dembinsky; Sten Rubertsson; Bengt Nellgård; Kaj Blennow; Henrik Zetterberg; Kirsty Spalding; Michael J Haller; Clive H Wasserfall; Desmond A Schatz; Carla J Greenbaum; Craig Dorrell; Markus Grompe; Aviad Zick; Ayala Hubert; Myriam Maoz; Volker Fendrich; Detlef K Bartsch; Talia Golan; Shmuel A Ben Sasson; Gideon Zamir; Aharon Razin; Howard Cedar; A M James Shapiro; Benjamin Glaser; Ruth Shemer; Yuval Dor
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

Review 9.  Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer.

Authors:  Christoph Plass; Stefan M Pfister; Anders M Lindroth; Olga Bogatyrova; Rainer Claus; Peter Lichter
Journal:  Nat Rev Genet       Date:  2013-10-09       Impact factor: 53.242

10.  GLI2-dependent c-MYC upregulation mediates resistance of pancreatic cancer cells to the BET bromodomain inhibitor JQ1.

Authors:  Krishan Kumar; Sania S Raza; Lawrence M Knab; Christina R Chow; Benjamin Kwok; David J Bentrem; Relja Popovic; Kazumi Ebine; Jonathan D Licht; Hidayatullah G Munshi
Journal:  Sci Rep       Date:  2015-03-25       Impact factor: 4.379

View more
  133 in total

Review 1.  Super-Enhancer-Driven Transcriptional Dependencies in Cancer.

Authors:  Satyaki Sengupta; Rani E George
Journal:  Trends Cancer       Date:  2017-04-12

Review 2.  Towards quantitative analysis of gene regulation by enhancers.

Authors:  Ekaterina V Nizovtseva; Stefjord Todolli; Wilma K Olson; Vasily M Studitsky
Journal:  Epigenomics       Date:  2017-08-11       Impact factor: 4.778

Review 3.  Transcriptional Addiction in Cancer.

Authors:  James E Bradner; Denes Hnisz; Richard A Young
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

4.  MCF-7 as a Model for Functional Analysis of Breast Cancer Risk Variants.

Authors:  Alix Booms; Gerhard A Coetzee; Steven E Pierce
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-07-10       Impact factor: 4.254

Review 5.  New insights of extrachromosomal DNA in tumorigenesis and therapeutic resistance of cancer.

Authors:  Hui Qiu; Zhi-Ying Shao; Xin Wen; Long-Zhen Zhang
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

6.  Informational limits of biological organisms.

Authors:  Jussi Taipale
Journal:  EMBO J       Date:  2018-04-18       Impact factor: 11.598

7.  Enhancers as regulators of antigen receptor loci three-dimensional chromatin structure.

Authors:  E Mauricio Barajas-Mora; Ann J Feeney
Journal:  Transcription       Date:  2019-12-12

8.  HOXA9 Reprograms the Enhancer Landscape to Promote Leukemogenesis.

Authors:  Yuqing Sun; Bo Zhou; Fengbiao Mao; Jing Xu; Hongzhi Miao; Zhenhua Zou; Le Tran Phuc Khoa; Younghoon Jang; Sheng Cai; Matthew Witkin; Richard Koche; Kai Ge; Gregory R Dressler; Ross L Levine; Scott A Armstrong; Yali Dou; Jay L Hess
Journal:  Cancer Cell       Date:  2018-09-27       Impact factor: 31.743

9.  A Somatically Acquired Enhancer of the Androgen Receptor Is a Noncoding Driver in Advanced Prostate Cancer.

Authors:  David Y Takeda; Sándor Spisák; Ji-Heui Seo; Connor Bell; Edward O'Connor; Keegan Korthauer; Dezső Ribli; István Csabai; Norbert Solymosi; Zoltán Szállási; David R Stillman; Paloma Cejas; Xintao Qiu; Henry W Long; Viktória Tisza; Pier Vitale Nuzzo; Mersedeh Rohanizadegan; Mark M Pomerantz; William C Hahn; Matthew L Freedman
Journal:  Cell       Date:  2018-06-14       Impact factor: 41.582

10.  CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification.

Authors:  Jae Young Hur; Hyeong Ryul Kim; Jung Yeon Lee; Sojung Park; Ji An Hwang; Woo Sung Kim; Shinkyo Yoon; Chang-Min Choi; Jin Kyung Rho; Jae Cheol Lee
Journal:  Cell Oncol (Dordr)       Date:  2019-03-05       Impact factor: 6.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.